| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |